SCHEMBL5689569

SCHEMBL5689569

O=C(Oc1ccc(CCSc2ccccn2)cc1)N1CCC(On2ccnc2)CC1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
FAAH O00519 2/20 0.39
POLB P06746 1/20 0.39
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
GRIN2B Q13224 1/20 0.36
GAA P10253 1/20 0.36
LIPE Q05469 1/20 0.36
ALDH1A1 P00352 4/20 0.36
NPY2R P49146 1/20 0.35
CYP3A4 P08684 2/20 0.35
TSHR P16473 2/20 0.35
HSD17B10 Q99714 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35
MAPK1 P28482 1/20 0.35
CYP2C19 P33261 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
REN P00797 1/20 0.35
MGLL Q99685 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5689664 0.88 GRIN2B (0.39) POLBGRIN2BLIPERENMGLL
SCHEMBL5689947 0.86 ALDH1A1 (0.37) FAAHPOLBNPC1RAB9AGRIN2B
SCHEMBL5687653 0.86 POLB (0.42) POLBNPC1RAB9AGRIN2BGAA
SCHEMBL5688744 0.85 GRIN2B (0.38) FAAHNPC1RAB9AGRIN2BGAA
SCHEMBL5689174 0.84 HSD11B1 (0.40) FAAHNPC1RAB9AGRIN2BGAA
SCHEMBL5689863 0.84 RAB9A (0.37) FAAHPOLBNPC1RAB9AALDH1A1
SCHEMBL5690784 0.84 FAAH (0.39) FAAHNPC1RAB9AGAALIPE
SCHEMBL5691062 0.81 FAAH (0.40) FAAHNPC1RAB9AALDH1A1NPY2R
SCHEMBL5689283 0.81 FAAH (0.37) FAAHNPC1RAB9AGRIN2BGAA
SCHEMBL5687570 0.80 POLB (0.47) POLBNPC1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060160851-A1 Substituted piperidine carbamates NOVO NORDISK A/S (DK) 2006-07-20 US claimed
EP-1636207-A1 SUBSTITUTED PIPERIDINE CARBAMATES FOR USE AS INHIBITORS OF HORMONE SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2006-03-22 EP claimed
WO-2004111032-A1 SUBSTITUTED PIPERIDINE CARBAMATES FOR USE AS INHIBITORS OF HORMONE SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2004-12-23 WO claimed
US-20060160851-A1 Substituted piperidine carbamates NOVO NORDISK A/S (DK) 2006-07-20 US disclosed
EP-1636207-A1 SUBSTITUTED PIPERIDINE CARBAMATES FOR USE AS INHIBITORS OF HORMONE SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2006-03-22 EP disclosed
WO-2004111032-A1 SUBSTITUTED PIPERIDINE CARBAMATES FOR USE AS INHIBITORS OF HORMONE SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2004-12-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060160851-A1 Substituted piperidine carbamates LIPE, PNLIP, LIPC FAAH 160/4885POLB 1797/4885NPC1 601/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.